Literature DB >> 36264650

Repurposing Antihypertensive Drugs for the Prevention of Glaucoma: A Mendelian Randomization Study.

Jingjing Liu1, Shuang Li2, Yang Hu3, Shizheng Qiu3.   

Abstract

Purpose: Several antihypertensive drugs have been used for the treatment of glaucoma. However, the effect of hypertension and antihypertensive drugs on glaucoma is still unclear.
Methods: Leveraging large-scale genome-wide association study summary statistics for glaucoma (Ncase = 4737, Ncontrol = 458,196), blood pressure (BP) (N = 422,771), and intraocular pressure (IOP) (N = 31,269), the genetic correlation and causal relationship of genetically assessed IOP, systolic blood pressure (SBP), diastolic blood pressure (DBP), and 12 types of antihypertensive drugs with glaucoma were evaluated using linkage disequilibrium score (LDSC) regression, univariate mendelian randomization (MR), and multivariable MR.
Results: LDSC results showed a suggestive association of glaucoma with SBP (Rg = 0.12, P = 0.0076) and DBP (Rg = 0.17, P = 0.02). In univariate MR, genetically elevated BP in participants was not identified to lead to an increased glaucoma risk (SBP: odds ratio [OR], 1.05 [95% confidence interval {CI}, 0.91-1.21]; P = 0.52; DBP: OR, 1.07 [95% CI, 0.93-1.23]; P = 0.34). The results of univariate MR were replicated in multivariable MR (SBP: OR, 0.95 [95% CI, 0.71-1.29]; P  = 0.75; DBP: OR, 1.13 [95% CI, 0.85-1.51]; P  = 0.41). Furthermore, there was insufficient evidence to suggest that antihypertensive drugs were associated with glaucoma. Conclusions: Together, controlling BP may not help prevent and treat glaucoma, and antihypertensive drugs may neither treat nor worsen glaucoma. Translational Relevance: Treating with antihypertensive drugs should not be used as an intervention for patients with glaucoma.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36264650      PMCID: PMC9587511          DOI: 10.1167/tvst.11.10.32

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.048


  40 in total

1.  Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy.

Authors:  Anna Neustaeter; Jelle Vehof; Harold Snieder; Nomdo M Jansonius
Journal:  Eye (Lond)       Date:  2020-06-18       Impact factor: 3.775

2.  Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study.

Authors:  Lauren Patty; Cathy Wu; Mina Torres; Stanley Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2012-04-25       Impact factor: 12.079

3.  Blood pressure, perfusion pressure, and open-angle glaucoma.

Authors:  Alfred Sommer; James Tielsch
Journal:  Arch Ophthalmol       Date:  2008-05

4.  Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study.

Authors:  I Dielemans; P T de Jong; R Stolk; J R Vingerling; D E Grobbee; A Hofman
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

5.  BIN1 rs744373 located in enhancers of brain tissues upregulates BIN1 mRNA expression, thereby leading to Alzheimer's disease.

Authors:  Shizheng Qiu; Yang Hu; Liang Cheng
Journal:  Alzheimers Dement       Date:  2022-01-03       Impact factor: 16.655

Review 6.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

7.  UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

Authors:  Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

8.  Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis.

Authors:  Ananth Viswanathan; Claudio Spera; Anmol Mullins; David Covert; Judit Banhazi; Paul McDwyer; Eibhlin Hudson; Alberto Ferreira
Journal:  Adv Ther       Date:  2017-05-30       Impact factor: 3.845

9.  Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study.

Authors:  Venexia M Walker; Patrick G Kehoe; Richard M Martin; Neil M Davies
Journal:  Int J Epidemiol       Date:  2020-08-01       Impact factor: 7.196

10.  Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study.

Authors:  Anthony P Khawaja; Michelle P Y Chan; David C Broadway; David F Garway-Heath; Robert Luben; Jennifer L Y Yip; Shabina Hayat; Nicholas J Wareham; Kay-Tee Khaw; Paul J Foster
Journal:  Ophthalmology       Date:  2014-04-02       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.